About Arnatar Therapeutics
We are a biotechnology company pioneering RNA-based therapeutics to address high unmet medical needs in cardiovascular, metabolic, liver, and kidney diseases.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
San Diego, United States
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
arnatar.com
Domain Registered Date
Dec 11, 2021
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Series-A announced
startupintros.com
- Capital Raise
Raised $52,000,000 · Series-A
startupintros.com
- Milestone
X account created (@ArnatarThera)
8 followers
- Milestone
Website domain registered
arnatar.com
Investors & Backers
3E Bioventures
Eight Roads Ventures
F-Prime Capital
Gaorong Capital
Hongsheng Capital
Huajin Capital
jifeng ventures
New Alliance Capital
Transfar Capital
Yijing Capital
Funding History
Series-A
· Mar 14, 2026
Undisclosed startupintros.com
Series-A
· Aug 25, 2025
$52,000,000 startupintros.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026